Cases & Deals

Bryan, Garnier & Co Limited and Chardan Capital Markets complete €25 million private placement of shares by GenSight Biologics S.A.

Clients Bryan, Garnier & Co Limited and Chardan Capital Markets, LLC

Jones Day represented Bryan, Garnier & Co Limited and Chardan Capital Markets, LLC in connection with the €25 million private placement of shares by GenSight Biologics S.A., a French clinical-stage gene therapy company in the area of severe retinal neurodegenerative diseases.